Genentech Hemophilia A Drug Displays Long-term Safety, Efficacy

Genentech’s Hemlibra® (emicizumab-kxwh) showed no new safety signals and continued to deliver consistent bleeding control in the final analysis of a long-term, late-stage hemophilia A study.